These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 430270
21. Aspartame. Review of safety issues. Council on Scientific Affairs. JAMA; 1985 Jul 19; 254(3):400-2. PubMed ID: 2861297 [Abstract] [Full Text] [Related]
24. Effect of elevated plasma phenylalanine levels on other amino acids in phenylketonuric and normal subjects. Efron ML, Kang ES, Visakorpi J, Fellers FX. J Pediatr; 1969 Mar 19; 74(3):399-405. PubMed ID: 5764775 [No Abstract] [Full Text] [Related]
26. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients. Mackey SA, Berlin CM. Clin Pediatr (Phila); 1992 Jul 19; 31(7):394-9. PubMed ID: 1617863 [Abstract] [Full Text] [Related]
27. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine. Jagenburg R, Rödjer S. Clin Chem; 1977 Sep 19; 23(9):1661-5. PubMed ID: 890910 [Abstract] [Full Text] [Related]
33. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Trefz F, de Sonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H. Hum Genet; 1994 Apr 19; 93(4):369-74. PubMed ID: 8168806 [Abstract] [Full Text] [Related]
39. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared. Jagenburg R, Regårdh CG, Rödjer S. Clin Chem; 1977 Sep 19; 23(9):1654-60. PubMed ID: 890909 [Abstract] [Full Text] [Related]